Trevor Dorne

Trevor Dorne

Associate

Trevor Dorne is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati.

Experience

Trevor Dorne is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati.

Education

J.D., University of San Diego School of Law, 2023
Dean’s Outstanding Scholar; Order of Barristers; 1^st Place Best Draft and 1^st Place Best Negotiation, 2023 UCLA National Transactional Law Competition; 1^st Place Best Draft, 2^nd Place Best Negotiation, and 1^st Place Best Overall, 2022 Duke University National Interscholastic Transactional Law Competition; CALI Excellence for the Future Award; Honor Court Representative, Student Bar Association
A.B., University of Southern California

Admissions

State Bar of California

Credentials

Education

J.D., University of San Diego School of Law, 2023
Dean’s Outstanding Scholar; Order of Barristers; 1^st Place Best Draft and 1^st Place Best Negotiation, 2023 UCLA National Transactional Law Competition; 1^st Place Best Draft, 2^nd Place Best Negotiation, and 1^st Place Best Overall, 2022 Duke University National Interscholastic Transactional Law Competition; CALI Excellence for the Future Award; Honor Court Representative, Student Bar Association
A.B., University of Southern California

Admissions

State Bar of California

Corporate

Recent Insights

Client Highlights

On September 11, 2024, SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), announced a $50 million Series B funding round. The round was led by Johnson & Johnson Innovation - JJDC, Inc. and joined by S3 Ventures, Lumira Ventures, SV Health Investors, Deerfield Management, NovaVenture, and Heartwork Capital. Wilson Sonsini Goodrich & Rosati advised SpectraWAVE on the transaction.

The funding round will be used to advance commercial expansion and product additions to the company’s 510k-cleared HyperVue™ Imaging System. HyperVue is the first intravascular imaging technology to combine two important imaging technologies, DeepOCT and NIRS, while optimizing for image quality and procedural efficiency in the cath lab, including no-flush catheter prep, fast and long pullbacks designed to reduce and remove the use of contrast, and the most comprehensive AI-driven workflow and image analysis offering.

The Wilson Sonsini team that advised SpectraWAVE includes Jason Skolnik, Brandon Shaw, Trevor Dorne, and Stephanie Chen.

Learn More

Client Highlights

On May 2, 2024, Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to pushing the boundaries of neuroscience, announced the close of a $103 million Series A financing co-led by Novo Holdings and MPM BioImpact, with participation from Arkin Bio Capital, Mitsui & Co. Global Investment, Plaisance Capital, FemHealth Ventures, and Palo Santo. Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction.

Learn More